Skip to content

Clinical trials

Pulmonary Disease, Chronic Obstructive trials in Spain with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Not applicable Country / region: Spain Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20053
20061
20072
20081
20092
20102
20112
20126
20138
20143
20152
20161
20174
20186
20194
20201
20221
20231
20246
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Unknown status20
Recruiting5
Not yet recruiting2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Universidad de Granada8
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina4
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau4
Basque Health Service3
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia2
Hospital de Mataró2
Parc de Salut Mar2
Sociedad Española de Neumología y Cirugía Torácica2
Air Liquide Healthcare Spain1
Andalusian School of Public Health1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive63
Heart Failure6
Diabetes Mellitus5
Hypertension4
Emphysema3
Lung Diseases3
Asthma2
Dyspnea2
Schizophrenia2
Stroke2

Trials

Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.